Microtuble-associated protein 2 (MAP2) is a protein that plays a crucial role in the regulation of microtubule dynamics and interactions, essential in neurogenesis. Biosensis’s validated MAP2 antibodies are designed to help users identify MAP2, whether they are detecting MAP2a, MAP2b or the distinctive MAP2c variant.
The company’s antibodies for MAP2 variants include antibodies that specifically target MAP2a and MAP2b, demonstrating high performance in western blots, as well as antibodies that identify all four MAP2 variants. They are distributed in Australia and New Zealand by Sapphire Bioscience.
Phone: 02 9698 2022
Lumiprobe DusQ fluorescence quenchers
Lumiprobe offers a series of DusQ fluorescence quenchers with different spectral properties and...
Enzo Life Sciences SCREEN-WELL Epigenetics library
Enzo Life Sciences' SCREEN-WELL Epigenetics library contains 43 compounds with defined...
LSBio PathPlus Cancer Antibodies
The LSBio PathPlus Cancer series of antibodies include both well-established biomarkers of cancer...
